News | September 26, 2024
Biocon Biologics Global to raise funds through senior secured notes
The Notes shall not be offered or sold in India
The Notes shall not be offered or sold in India
She reiterated the nation's commitment to eliminating TB as a public health problem by 2030 and ensuring a healthier future for all
NMC to continue its efforts to improve and enhance the quality of medical education in the country
These clinical studies support the interchangeability of adalimumab-fkjp at low-concentration with high-concentration adalimumab and ustekinumab biosimilarity
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
Doses will be ready to ship to applicable European Union (EU) member states as soon as possible upon European Commission (EC) authorization
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
ACOIN has recognized Dr. Budhrani's exceptional work in promoting community and clinical ophthalmology
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
Subscribe To Our Newsletter & Stay Updated
